Advancing Malaria Solutions: Enhancing Drug Development, Access, and Global Health Equity

​Global efforts are ongoing to address the significant health challenge posed by malaria, which resulted in an estimated 263 million cases and 597,000 deaths in 2023. However, there remains an urgent need for further progress to protect and treat the most vulnerable populations.

​The panel discussion will focus on current initiatives aimed at promoting health equity, enhancing drug development efficiency, and improving access to affordable treatments for patients worldwide.

​The panel will explore key opportunities to optimize pharmaceutical and manufacturing processes, reduce the cost of active ingredients, and improve distribution strategies globally, all of which are essential to advancing solutions for the unmet needs in malaria treatment.